BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma. | Oncogene;25(33): 4525-33, 2006 Aug 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

BH3 peptidomimetics potently activate apoptosis and demonstrate single agent efficacy in neuroblastoma.

Goldsmith, K C; Liu, X; Dam, V; Morgan, B T; Shabbout, M; Cnaan, A; Letai, A; Korsmeyer, S J; Hogarty, M D.

Affiliation

Goldsmith KC; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Oncogene ; 25(33): 4525-33, 2006 Aug 03.

Article in En | MEDLINE | ID: mdl-16568093

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Proto-Oncogene Proteins / Apoptosis / Neuroblastoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2006 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / Proto-Oncogene Proteins / Apoptosis / Neuroblastoma Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2006 Document type: Article Affiliation country: Country of publication: